Table of Contents PART 01: Executive summary PART 02: Scope of  the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights Epinephrine autoinjector: Overview PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation  by dosage Global epinephrine autoinjector market by 0.15gm dosage Global epinephrine autoinjector market by 0.30gm dosage Global epinephrine autoinjector market by 0.5gm dosage PART 07: Market segmentation by age group PART 08: Market segmentation by end-user Hospitals and clinics Individuals PART 09: Geographical segmentation Epinephrine autoinjector market in the Americas Epinephrine autoinjector market in EMEA Epinephrine autoinjector market in APAC PART 10: Market drivers Increasing prevalence of allergies Technological advances Marketing strategies PART 11: Impact of drivers PART 12: Market challenges Product recalls and regulatory issues Presence of substitutes High cost PART 13: Impact of drivers and challenges PART 14: Market trends Tentative product launches Growing awareness about epinephrine autoinjectors Patient assistance programs PART 15: Vendor landscape Competitive scenario Key news Geographical presence of key vendors PART 16: Key vendor analysis ALK-Abelló Impax Laboratories Lincoln Medical Mylan Other prominent vendors PART 17: Appendix List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global epinephrine autoinjector market: Analysis Exhibit 03: Key buying criteria for epinephrine autoinjectors Exhibit 04: Buying criteria for epinephrine autoinjectors Exhibit 05: Key factors influencing development of epinephrine autoinjectors Exhibit 06: Allergy statistics Exhibit 07: Market overview: Global epinephrine autoinjector market Exhibit 08: Global epinephrine autoinjector market ($ millions) Exhibit 09: Global epinephrine autoinjector market analysis: Developed and developing markets Exhibit 10: Five forces analysis Exhibit 11: Global epinephrine autoinjector market segmentation by dosage 2016 Exhibit 12: Global epinephrine autoinjector market segmentation by dosage 2020 Exhibit 13: Global epinephrine autoinjector market by 0.15gm dosage 2016-2021 ($ millions) Exhibit 14: Global epinephrine autoinjector market by 0.30gm dosage 2016-2021 ($ millions) Exhibit 15: Global epinephrine autoinjector market by 0.5gm dosage 2016-2021 ($ millions) Exhibit 16: Global epinephrine autoinjector market segmentation by dosage 2016-2021 (%) Exhibit 17: Global epinephrine autoinjector market segmentation by dosage 2016-2021 ($ millions) Exhibit 18: Global epinephrine autoinjector market by age group 2016 Exhibit 19: Global epinephrine autoinjector market by end-user 2016 Exhibit 20: Global epinephrine autoinjector market segmentation by geography 2016 Exhibit 21: Global epinephrine autoinjector market segmentation by geography 2021 Exhibit 22: Epinephrine autoinjector market in the Americas 2016-2021 ($ millions) Exhibit 23: Market overview: Americas Exhibit 24: Epinephrine autoinjector market overview: US Exhibit 25: Epinephrine autoinjector market in the US 2016-2021 ($ millions) Exhibit 26: Market overview: EMEA Exhibit 27: Epinephrine autoinjector market in EMEA 2016-2021 ($ millions) Exhibit 28: Market overview: APAC Exhibit 29: Epinephrine autoinjector market in APAC 2016-2021 ($ millions) Exhibit 30: Global epinephrine autoinjector market segmentation by geography 2016-2021 ($ millions) Exhibit 31: Global epinephrine autoinjector market segmentation by geography 2016-2021 (%) Exhibit 32: Allergy statistics Exhibit 33: Technological advances Exhibit 34: Marketing strategies of Mylan Exhibit 35: Impact of drivers Exhibit 36: Product recalls Exhibit 37: Alternatives of epinephrine autoinjectors in the market Exhibit 38: Impact of drivers and challenges Exhibit 39: Competitive structure of the global epinephrine autoinjector market Exhibit 40: Market penetration of various epinephrine autoinjector manufacturers globally (2016) Exhibit 41: Strategic success factors of companies in global epinephrine autoinjector market 2016 Exhibit 42: Share of vendors in global epinephrine autoinjector market 2016 Exhibit 43: Regional analysis of key vendors Exhibit 44: Key highlights of ALK-Abelló Exhibit 45: ALK-Abelló strength assessment Exhibit 46: ALK-Abelló strategy assessment Exhibit 47: ALK-Abelló opportunity assessment Exhibit 48: Key highlights of Impax Laboratories Exhibit 49: Impax Laboratories strength assessment Exhibit 50: Impax Laboratories strategy assessment Exhibit 51: Impax Laboratories opportunity assessment Exhibit 52: Lincoln Medical strength assessment Exhibit 53: Lincoln Medical strategy assessment Exhibit 54: Lincoln Medical opportunity assessment Exhibit 55: Key highlights of Mylan Exhibit 56: Mylan strength assessment Exhibit 57: Mylan strategy assessment Exhibit 58: Mylan opportunity assessment

ALK-Abelló, Impax Laboratories, Lincoln Medical, Mylan, Adamis Pharmaceuticals, Antares Pharma, Emerade, Hospira, Kaleo Pharma, Teva Pharmaceutical Industries.